Schroder Investment Management Group Coherus Bio Sciences, Inc. Transaction History

Schroder Investment Management Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$17.41 - $19.89 $612,570 - $699,829	-35,185 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$14.43 - $19.16 $6.33 Million - $8.4 Million	-438,526 Reduced 92.57%	35,185 $629,000
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $5.53 Million - $10.7 Million	473,711 New	473,711 $7.56 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.